Viewing Study NCT00834405


Ignite Creation Date: 2025-12-25 @ 3:24 AM
Ignite Modification Date: 2025-12-26 @ 2:04 AM
Study NCT ID: NCT00834405
Status: COMPLETED
Last Update Posted: 2024-08-19
First Post: 2009-01-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Leflunomide 20 mg Tablets, Non-Fasting
Sponsor: Teva Pharmaceuticals USA
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2002-04
Start Date Type: None
Primary Completion Date: 2002-05
Primary Completion Date Type: ACTUAL
Completion Date: 2002-05
Completion Date Type: ACTUAL
First Submit Date: 2009-01-30
First Submit QC Date: None
Study First Post Date: 2009-02-03
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2009-07-02
Results First Submit QC Date: None
Results First Post Date: 2009-08-18
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-08-15
Last Update Post Date: 2024-08-19
Last Update Post Date Type: ACTUAL